RI

Active Director Director DIN 07163795
DIN 07163795 First appointment Jul 2015 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Ravi Ika

Data last updated:

Ravi Ika is a Director at Rxadvance Pbm India Private Limited (since 2015). The company operates in Information Technology. Rxadvance Pbm India Private Limited reported revenue of ₹33.87 Cr (FY 2025).

DIN 07163795
Primary Designation Director
Industry Information Technology
First Appointment 06 Jul 2015
Oldest Company Age 11 yrs
Largest company Rxadvance Pbm India Private Limited · ₹33.87 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rxadvance Pbm India Private Limited U72300UP2015FTC071836
Director06 Jul 20152015₹33.87 Cr (FY 2025)Active

Board colleagues of Ravi Ika

Directorship timeline

Open interactive timeline →
Rxadvance Pbm India Private Limited
Premium access

Shareholding and investment profile for Ravi Ika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Ika

Ravi Ika currently holds 1 directorship: Rxadvance Pbm India Private Limited (Director, since 06 Jul 2015, revenue ₹33.87 Cr (FY 2025)).

Ravi Ika was first appointed on 06 Jul 2015 as Director at Rxadvance Pbm India Private Limited.

The current boards of Ravi Ika's companies include Bijendra Pal Malik (Rxadvance Pbm India Private Limited), Madusudhana Rao Narahari (Rxadvance Pbm India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available